Since oxidative stress, inflammation, and impaired proteostasis are significantly involved in the pathogenesis of AD [7], the KEAP1-NRF2 system has emerged as a promising therapeutic target for the disease [8]. This evidence concerns the gene KEAP1 and Alzheimer disease.